Sector News

Study suggests AI could provide second reading of mammograms

September 15, 2023
Life sciences

AI solutions have proliferated in medical imaging, where ample data is available to train algorithms to detect cancer, stroke and other serious conditions. Lunit’s Insight MMG solution has received 510(k) clearance from the Food and Drug Administration and a CE mark in Europe. Other competitors in the space include iCAD and ScreenPoint Medical.

The prospective study included more than 58,000 women who had regular mammography screenings at Capio Sankt Göran Hospital in Stockholm. Consistent with usual care at the hospital, if any of the readers reported abnormal findings, two radiologists would have a consensus discussion before deciding whether to send patients for additional imaging.

The study found that readings from a radiologist and an AI reader resulted in a 4% increase in screen-detected cancers, or about 11 more cases, compared to two radiologists. However, the AI-radiologist duo also caused a 21% increase in the number of examinations with an abnormal interpretation, resulting in more consensus discussions. This did not translate into an increased recall rate for additional imaging. READ MORE

by Elise Reuter


comments closed

Related News

July 14, 2024

Flagship raises $3.6B for biotech investing

Life sciences

Flagship Pioneering said Wednesday that it’s added another $3.6 billion to its capital base, bringing the total raised since 2021 to $6.4 billion. Meanwhile, Flagship announced more than a dozen promotions and new hires in its leadership ranks. The changes include the promotions of Lovisa Afzelius and Paul Biondi to general partner and the addition of Dina Ciarimboli as general counsel and executive partner.

July 14, 2024

Mikael Dolsten set to leave Pfizer, sparking search for CSO successor

Life sciences

After 15 years at Pfizer, including a career-defining pandemic period, the chief scientific officer will leave the Big Pharma once the drugmaker finds his successor. Dolsten joined Pfizer when the company closed a megamerger with Wyeth in 2009. Pfizer made Dolsten president of worldwide R&D the following year. The executive has stayed at the top of Pfizer’s R&D tree ever since.

July 14, 2024

CDMO Lotte breaks ground on $3.3B production plant in Korea, touts growth goals

Life sciences

Late last week, Lotte Biologics broke ground on its flagship facility at the Songdo Bio Campus in Incheon International City, South Korea. The company is pitching the production effort as a key part of its quest to become one of the top 10 contract development and manufacturing organizations (CDMOs) in the world, Lotte said in a press release.

How can we help you?

We're easy to reach